Evonik has today signed an agreement to sell its Methacrylates business to Advent International for €3 billion. The selling price (enterprise value) is 8.5 times the business’ EBITDA. Consistent strategy execution to focus on specialty chemicals Attractive selling price of €3 billion is 8.5 times the business’ EBITDA Excellent development opportunities for Methacrylate business Essen, … Continue reading Evonik agrees to sell its Methacrylates business to Advent International for €3 billion